4 MARCH 2026
Title Endoscopy Workshop
Details Date: 4 March 2026
Time: 0900hrs to 1200hrs
Venue Dusit Thani Laguna Singapore, Level 5, Albatross & Birdie
Format This workshop will combine didactic lectures, case-based discussions, and interactive sessions to ensure active learning and practical application of endoscopy and surgical concepts in the field of hereditary GI cancers.
Synopsis A national survey on knowledge and service gaps in hereditary gastrointestinal cancers among healthcare professionals in Singapore noted significant knowledge gaps in the identification and management of such patients. This half day review course has been meticulously designed to bridge the knowledge gap and enhance the identification, management and surveillance of such patients. We will explore key topics in endoscopy phenotypes, surgical advances and techniques and small bowel endoscopy of hereditary GI cancer patients, through a combination of expert-led lectures and case discussions.
Objectives By the end of the workshop, participants will be able to:
Be confident in endoscopic phenotypes of hereditary GI cancers:

  • Identify key endoscopic features of hereditary gastrointestinal cancer syndromes (e.g., FAP, Lynch syndrome, Peutz-Jeghers, serrated polyposis).
  • Differentiate hereditary cancer–associated lesions from sporadic polyps and other mimickers.
  • Recognize clinical and endoscopic red flags that should prompt referral for genetic testing.

Understand surgical advances & techniques in hereditary GI cancers:

  • Compare surgical approaches for hereditary versus sporadic GI cancers, including extent of resection and organ-preserving strategies.
  • Describe the role of novel surgical platforms (e.g., single-port robotic surgery) in the management of hereditary cancer patients.
  • Apply principles of individualized surgical planning for hereditary cancer patients, balancing oncologic safety with function preservation.

Appreciate small bowel surveillance and resection in Peutz–Jeghers (PJ) patients

  • Outline surveillance protocols for small bowel polyps in PJ patients.
  • Demonstrate techniques for safe endoscopic resection of large or complex small bowel polyps.
  • Anticipate and manage technical challenges and complications in small bowel surveillance and polyp removal.
Target Participants Gastroenterologists, Surgeons, Trainees
Faculty Dr Tan Yu Bin, Associate Consultant, Singapore General Hospital, Singapore
Dr Andrew Latchford, Consultant Gastroenterologist, St Mark’s National Bowel Hospital, United Kingdom
Dr Matthew Kalady, USA
Dr Ravishankar Asokkumar, Singapore
Dr Christopher Khor, Singapore
Schedule Time Description/Title Faculty
0900 – 0930 Endoscopic phenotypes of hereditary GI cancers Dr Tan Yu Bin
0930 – 1000 Case based / video discussions Dr Andrew Latchford
1000 – 1030 Surgical advances & techniques in hereditary GI cancers Dr Matthew Kalady
1030 – 1100 Case based / video discussions Dr Andrew Latchford
1100 – 1130 Small bowel endoscopy in hereditary GI cancers Dr Ravishankar Asokkumar / Dr Christopher Khor
1130 – 1200 Case based / video discussions Dr Ravishankar Asokkumar / Dr Christopher Khor
Registration Fee SGD 50 for Main Congress Attendee
SGD 400 for Non-Congress Attendee
No of pax 40 pax

Title

Hereditary Gastrointestinal (GI) Cancer Masterclass
Details Date: 4 March 2026

Time: 0900hrs to 1200hrs

Venue Dusit Thani Laguna Singapore, Level 3, Laguna Ballroom
Synopsis

The Hereditary Gastrointestinal (GI) Cancer Masterclass is a focused, expert-led educational session designed clinicians, trainees, researchers, nurses, genetic counsellors and anyone interested in strengthening their understanding of hereditary GI cancer syndromes.

This masterclass will introduce the fundamental principles of hereditary GI cancers, from recognising clinical patterns and understanding genetic mechanisms, to interpreting molecular test results and applying management strategies in practice. Participants will also gain insight into multidisciplinary care approaches through interactive case discussions.

Whether you are a clinician wanting to better identify hereditary risk, a researcher exploring translational applications, or a trainee seeking structured learning in hereditary oncology, this session provides a practical and engaging foundation to complement the broader InSiGHT 2026 scientific programme.

Objectives

By the end of the masterclass, participants will be able to:

  1. Understand the principles of hereditary GI cancer syndromes and their genetic basis.
  2. Recognise clinical features and family history patterns that suggest an inherited cancer predisposition.
  3. Describe the approach to genetic testing and variant interpretation for common hereditary GI syndromes.
  4. Outline current surveillance and management recommendations for affected individuals and at-risk relatives.
  5. Discuss real-world cases and multidisciplinary perspectives in diagnosis, counselling, and clinical decision-making.
Target Participants clinicians, trainees, researchers, nurses, genetic counsellors, and anyone interested to strengthen their understanding of hereditary GI cancer syndromes.
Faculty Heather Hampel Beckman Research Institute, City of Hope
Megan Hitchins Moffitt Cancer Centre, University of South Florida
Susan Clark St Mark’s The National Bowel Hospital
Sonia Kupfer Gastrointestinal Cancer Risk and Prevention Clinic, University of Chicago
Francesc Balaguer Gastroenterology Department, Hospital Clinic of Barcelona
Schedule Time Description/Title Faculty

0900 – 0930

Hereditary GI Genomics Heather Hampel (Canada)

0930 – 1000

Epimutations in Hereditary GI cancers Megan Hitchins (USA)

1000 – 1030

Management of Hereditary GI cancers Susan Clark (United Kingdom)

1030 – 1050

Break

1050 – 1130

Case Studies Sonia Kupfer (USA)

Francesc Balaguer (Spain)

Cost per pax Complimentary for InSiGHT Delegates

CONTACT US

Kenes MP Asia Pte Ltd
20 Kallang Avenue, PICO Creative Centre, Level 2
Singapore 339411

General Inquiries

Registration Inquiries

Abstract Inquiries